Immunomedics, Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 4,962 32,734 14,709 60,930
Cost of Revenue 393 427 419 960
Gross Profit 4,569 32,307 14,290 59,970
Operating Expenses
Research and Development 28,381 24,256 24,537 19,854
Sales, General and Admin. 6,981 6,609 7,944 6,183
Non-Recurring Items - - - -
Other - - - -
Operating Income (30,792) 1,443 (18,191) 33,933
Income From Continuing Operations
Add'l Income/Expense Items 19,350 32 3,888 1,834
Earnings Before Interest and Tax (11,442) 1,475 (14,302) 35,767
Interest Expense - - - -
Earnings Before Tax (11,442) 1,475 (14,302) 35,767
Income Tax 44 210 110 (1,229)
Minority Interest (105) (114) (174) -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,382) 1,378 (14,238) 36,996
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,382) 1,378 (14,238) 36,996
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,382) 1,378 (14,238) 36,996